📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Salmonella cancer therapy metabolically disrupts tumours at the collateral cost of T cell immunity. (2024)

First Author: Copland A

Attributed to: Interrogating NRK1 activity as a central regulator of CD4+ T cell metabolism, fate and function funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1038/s44321-024-00159-2

PubMed Identifier: 39558103

Publication URI: http://europepmc.org/abstract/MED/39558103

Type: Journal Article/Review

Volume: 16

Parent Publication: EMBO molecular medicine

Issue: 12

ISSN: 1757-4676